42
Participants
Start Date
July 31, 2007
Primary Completion Date
February 28, 2011
Study Completion Date
March 31, 2011
Albutein 5%
"18 Plasma Exchanges using Albutein 5%:~* three weeks of intensive treatment with two plasma exchanges per week~* six weeks of maintenance treatment with one weekly plasma exchange~* three months of maintenance treatment with one plasma exchange every two weeks"
Control
Control group followed the same schedule; however, they did not undergo plasma replacement (it was subjected to simulated plasma replacements)
Howard University, Washington D.C.
Hospital General Universitario Gregorio Marañon, Madrid
Mid-Atlantic Geriatric/ARC, Whiting
Fundació ACE, Barcelona
Grifols Biologicals, LLC
INDUSTRY
Instituto Grifols, S.A.
INDUSTRY